Dr. Joshua M. Hare Leads Miller School Participants at World Stem Cell Summit
The University of Miami Miller School of Medicine made a splash at the prestigious 12th Annual World Stem Cell Summit (WSCS), with high-profile participation from the Interdisciplinary Stem Cell Institute (ISCI) and physicians and researchers from other departments. Joshua M. Hare, M.D., the Louis Lemberg Professor of Medicine, founding Director of ISCI, and one of the chairs of the Summit, and Camillo Ricordi, M.D., Director of the Diabetes Research Institute and the Cell Transplant Program at the Miller School, and a Summit co-chair, gave opening remarks. Ricordi was also the 2016 Advocacy Award recipient for his exemplary advocate achievements in the field of stem cell research (see related story).
The University showcased its span of research and clinical care at a special panel that included Hare, Evangelos Badiavas, M.D., Ph.D., Bradley J. Goldstein, M.D., Ph.D., Kostantinos Hatzistergos, Ph.D., Claudia O. Rodrigues, M.S., Ph.D., Robert M. Starke, M.D., Dileep R. Yavagal, M.D., and Karen C. Young, M.D.
The WSCS represents the entire stem cell ecosystem; the summit connects decision makers, scientists and influencers as they share latest discoveries, discuss issues in the field and collaborate on new projects in regenerative medicine. Throughout the summit, ISCI and other University of Miami physicians and researchers presented their latest research and discoveries related to a variety of topics.
Hare shared his latest study results and discussed advancements of stem cell use in cardiology. He also delved into the thought-provoking debate of why mesenchymal stem cells are not stem cells. Bernie Marcus, Chairman of the Marcus Foundation and a generous supporter of ISCI, joined Hare and other panelists for a discussion on strategic philanthropic goals in the field.
Ricordi spoke on new developments in diabetes research and gave a presentation on overcoming regulatory roadblocks. Diego Correa, M.D., M.Sc., Ph.D., spoke on the clinical applications for regenerative medicine and the use of stem cells in treating sports injuries.
Other topical presentations included Daniel Pelaez on vision restoration using stem cells, Charles B. Nemeroff, M.D., Ph.D., on his findings on Regenerative Medicine and Mental Health, and Rosario Isasi, J.D., M.P.H. on ethical considerations for gene editing.
Additionally, Darcy L. DiFede, B.S.N., RN answered questions during the Public Day on how to choose the right clinical trial, in which members of the community joined the conference to learn more about stem cell therapies and upcoming clinical trials.